scholarly journals Effects of Vagus Nerve Stimulation in a Murine Model of Systemic Lupus Erythematosus

2018 ◽  
Vol 32 (S1) ◽  
Author(s):  
Keisa W. Mathis ◽  
Harald Stauss ◽  
Grace S. Pham ◽  
Suhhyun S. Kim ◽  
Denis V. Kulp
2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Charrise M. Ramkissoon ◽  
Amparo Güemes ◽  
Josep Vehi

AbstractSystemic lupus erythematosus (SLE) is a chronic systemic autoimmune disorder that commonly affects the skin, joints, kidneys, and central nervous system. Although great progress has been made over the years, patients still experience unfavorable secondary effects from medications, increased economic burden, and higher mortality rates compared to the general population. To alleviate these current problems, non-invasive, non-pharmacological interventions are being increasingly investigated. One such intervention is non-invasive vagus nerve stimulation, which promotes the upregulation of the cholinergic anti-inflammatory pathway that reduces the activation and production of pro-inflammatory cytokines and reactive oxygen species, culpable processes in autoimmune diseases such as SLE. This review first provides a background on the important contribution of the autonomic nervous system to the pathogenesis of SLE. The gross and structural anatomy of the vagus nerve and its contribution to the inflammatory response are described afterwards to provide a general understanding of the impact of stimulating the vagus nerve. Finally, an overview of current clinical applications of invasive and non-invasive vagus nerve stimulation for a variety of diseases, including those with similar symptoms to the ones in SLE, is presented and discussed. Overall, the review presents neuromodulation as a promising strategy to alleviate SLE symptoms and potentially reverse the disease.


2020 ◽  
pp. annrheumdis-2020-217872
Author(s):  
Cynthia Aranow ◽  
Yemil Atish-Fregoso ◽  
Martin Lesser ◽  
Meggan Mackay ◽  
Erik Anderson ◽  
...  

ObjectivesMusculoskeletal pain and fatigue are common features in systemic lupus erythematosus (SLE). The cholinergic anti-inflammatory pathway is a physiological mechanism diminishing inflammation, engaged by stimulating the vagus nerve. We evaluated the effects of non-invasive vagus nerve stimulation in patients with SLE and with musculoskeletal pain.Methods18 patients with SLE and with musculoskeletal pain ≥4 on a 10 cm Visual Analogue Scale were randomised (2:1) in this double-blind study to receive transcutaneous auricular vagus nerve stimulation (taVNS) or sham stimulation (SS) for 4 consecutive days. Evaluations at baseline, day 5 and day 12 included patient assessments of pain, disease activity (PtGA) and fatigue. Tender and swollen joint counts and the Physician Global Assessment (PGA) were completed by a physician blinded to the patient’s therapy. Potential biomarkers were evaluated.ResultstaVNS and SS were well tolerated. Subjects receiving taVNS had a significant decrease in pain and fatigue compared with SS and were more likely (OR=25, p=0.02) to experience a clinically significant reduction in pain. PtGA, joint counts and PGA also improved. Pain reduction and improvement of fatigue correlated with the cumulative current received. In general, responses were maintained through day 12. Plasma levels of substance P were significantly reduced at day 5 compared with baseline following taVNS but other neuropeptides, serum and whole blood-stimulated inflammatory mediators, and kynurenine metabolites showed no significant change at days 5 or 12 compared with baseline.ConclusiontaVNS resulted in significantly reduced pain, fatigue and joint scores in SLE. Additional studies evaluating this intervention and its mechanisms are warranted.


Lupus ◽  
1997 ◽  
Vol 6 (5) ◽  
pp. 436-440 ◽  
Author(s):  
YY Dhaher ◽  
MA Khamashta ◽  
B. Hartley ◽  
N. Taub ◽  
JC Farine ◽  
...  

Allergy ◽  
2019 ◽  
Vol 74 (9) ◽  
pp. 1748-1759 ◽  
Author(s):  
Goele Bosmans ◽  
Iris Appeltans ◽  
Nathalie Stakenborg ◽  
Pedro J. Gomez‐Pinilla ◽  
Morgane V. Florens ◽  
...  

2019 ◽  
Vol 199 (3) ◽  
pp. 278-293 ◽  
Author(s):  
N. Mihaylova ◽  
P. Chipinski ◽  
S. Bradyanova ◽  
T. Velikova ◽  
E. Ivanova‐Todorova ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document